Working… Menu

The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00371800
Recruitment Status : Completed
First Posted : September 4, 2006
Last Update Posted : September 4, 2006
Dartmouth College
Information provided by:
Dartmouth-Hitchcock Medical Center

Brief Summary:
the purpose of this study is to determine if cinnamon improves glucose control among adolescents with type 1 diabetes mellitus.

Condition or disease Intervention/treatment Phase
Type 1 Diabetes Mellitus Drug: cinnamon Phase 2 Phase 3

Detailed Description:

Widespread achievement of glucose control remains an elusive goal for adolescents with Type 1 diabetes. Previous research has suggested that cinnamon may be effective at improving glucose control in type 2 diabetes. To date, no research has investigated the effect of cinnamon on type 1 diabetics. If the addition of a simple, natural, pill to a standard insulin regimen can significantly improve glucose control, the clinical implications would be substantial.

Comparison: Using a prospective, double-blind, placebo-controlled design, 72 adolescent type I diabetics were treated with cinnamon (1 gram/day) or an equivalent appearing placebo for 90 days. HbA1c, total daily insulin intake, and adverse events were recorded and compared between groups.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 72 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes
Study Start Date : October 2005
Study Completion Date : May 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Diabetes Type 1

Primary Outcome Measures :
  1. HbA1c

Secondary Outcome Measures :
  1. Total Daily Insulin
  2. Carbohydrate/insulin dose
  3. Hypoglycemic events
  4. Compliance

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   13 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Diagnosis of Type 1 diabetes for > 18 months prior to enrollment,
  2. Age 13-18 years at the time of enrollment
  3. Presenting to the clinic for routine care,
  4. No hospital admissions for medical or psychiatric reasons in the 12 months prior to enrollment,
  5. Accessible by phone,
  6. Not pregnant.

Exclusion Criteria:

(1) Pregnant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00371800

Layout table for location information
United States, New Hampshire
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Sponsors and Collaborators
Dartmouth-Hitchcock Medical Center
Dartmouth College
Layout table for investigator information
Principal Investigator: Samuel J Casella, MD Dartmouth-Hitchcock Medical Center
Layout table for additonal information Identifier: NCT00371800    
Other Study ID Numbers: 17648
First Posted: September 4, 2006    Key Record Dates
Last Update Posted: September 4, 2006
Last Verified: August 2006
Keywords provided by Dartmouth-Hitchcock Medical Center:
Type 1 Diabetes
Additional relevant MeSH terms:
Layout table for MeSH terms
Diabetes Mellitus
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Autoimmune Diseases
Immune System Diseases